← Evidence map

TrialNature2024

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.

Jean E Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

36 papers cite it

2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38588696